Shanghai RAAS Blood Products Co., Ltd.
002252
Clasificación en acciones
#3570
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Precio por acción
$0.72625991
Capitalización bursátil
$4.79B
Cambio (1 día)
2.70%
Cambio (1 año)
-22.68%
País
CN
Comercio Shanghai RAAS Blood Products Co., Ltd. (002252)
Categoría
Healthcare
Ratio P/B de Shanghai RAAS Blood Products Co., Ltd. (002252)
Ratio P/B al October 2026 TTM: 1.01
Según los informes financieros más recientes y el precio de las acciones de Shanghai RAAS Blood Products Co., Ltd., el ratio P/B actual (TTM) es 1.01. Al final de 2023, el ratio P/B era 1.70.
Historial del ratio P/B de Shanghai RAAS Blood Products Co., Ltd. desde 2005 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 1.01 | -32.79% |
| 2024 | 1.50 | -11.55% |
| 2023 | 1.70 | 14.59% |
| 2022 | 1.48 | -16.45% |
| 2021 | 1.77 | -10.61% |
| 2020 | 1.99 | -39.37% |
| 2019 | 3.27 | -8.41% |
| 2018 | 3.58 | -54.12% |
| 2017 | 7.79 | -19.17% |
| 2016 | 9.64 | -6.16% |
| 2015 | 10.27 | 68.88% |
| 2014 | 6.08 | -86.55% |
| 2013 | 45.24 | 241.08% |
| 2012 | 13.26 | -5.97% |
| 2011 | 14.11 | -38.54% |
| 2010 | 22.95 | 46.93% |
| 2009 | 15.62 | 66.48% |
| 2008 | 9.38 | -68.34% |
| 2007 | 29.64 | 158.32% |
| 2006 | 11.47 | 47.63% |
| 2005 | 7.77 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 6.251 | 520.02% |
US
|
|
| 13.2547 | 1,214.69% |
US
|
|
| 4.208 | 317.38% |
AU
|
|
| 6.1824 | 513.21% |
NL
|
|
| - | - |
CH
|
